Abstract
The transcription factor p53 regulates the expression of genes crucial for biological processes such as cell proliferation, metabolism, cell repair, senescence and apoptosis. Activation of p53 also suppresses neoplastic transformations, thereby inhibiting the growth of mutated and/or damaged cells. p53-binding proteins, such as mouse double minute 2 homolog (MDM2), inhibit p53 activation and thus regulate p53-mediated stress responses. Here, we found that long glucocorticoid-induced leucine zipper (L-GILZ), a recently identified isoform of GILZ, activates p53 and that the overexpression of L-GILZ in p53+/+ HCT116 human colorectal carcinoma cells suppresses the growth of xenografts in mice. In the presence of both p53 and MDM2, L-GILZ binds preferentially to MDM2 and interferes with p53/MDM2 complex formation, making p53 available for downstream gene activation. Consistent with this finding, L-GILZ induced p21 and p53 upregulated modulator of apoptosis (PUMA) expression only in p53+/+ cells, while L-GILZ silencing reversed the anti-proliferative activity of dexamethasone as well as expression of p53, p21 and PUMA. Furthermore, L-GILZ stabilizes p53 proteins by decreasing p53 ubiquitination and increasing MDM2 ubiquitination. These findings reveal L-GILZ as a regulator of p53 and a candidate for new therapeutic anti-cancer strategies for tumors associated with p53 deregulation.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Abbreviations
- MDM2:
-
mouse double minute 2 homolog
- GC:
-
glucocorticoid
- GR:
-
glucocorticoid receptor
- GILZ:
-
glucocorticoid-induced leucine zipper
- L-GILZ:
-
long glucocorticoid-induced leucine zipper
- TSC:
-
TGF-β-stimulated clone
- DEX:
-
dexamethasone
- PLA:
-
proximity ligation assay
- MEFs:
-
mouse embryo fibroblasts
- PUMA:
-
p53 upregulated modulator of apoptosis
- ARF:
-
ADP ribosylation factors
- USP:
-
ubiquitin-specific protease
- IB:
-
immunoblot
- NU:
-
nude mice
- IP:
-
immunoprecipitation
- GST:
-
glutathione S-transferase
- Ub:
-
ubiquitin
References
Lane DP . Cancer. p53, guardian of the genome. Nature 1992; 358: 15–16.
Levine AJ . p53, the cellular gatekeeper for growth and division. Cell 1997; 88: 323–331.
Giaccia AJ, Kastan MB . The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev 1998; 12: 2973–2983.
Ko LJ, Prives C . p53: puzzle and paradigm. Genes Dev 1996; 10: 1054–1072.
Riley T, Sontag E, Chen P, Levine A . Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol 2008; 9: 402–412.
Vogelstein B, Lane D, Levine AJ . Surfing the p53 network. Nature 2000; 408: 307–310.
Van Dyke T . p53 and tumor suppression. N Engl J Med 2007; 356: 79–81.
Momand J, Zambetti GP, Olson DC, George D, Levine AJ . The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 1992; 69: 1237–1245.
Marine JC, Lozano G . Mdm2-mediated ubiquitylation: p53 and beyond. Cell Death Differ 2010; 17: 93–102.
Boyd SD, Tsai KY, Jacks T . An intact HDM2 RING-finger domain is required for nuclear exclusion of p53. Nat Cell Biol 2000; 2: 563–568.
Geyer RK, Yu ZK, Maki CG . The MDM2 RING-finger domain is required to promote p53 nuclear export. Nat Cell Biol 2000; 2: 569–573.
Stommel JM, Marchenko ND, Jimenez GS, Moll UM, Hope TJ, Wahl GM . A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking. EMBO J 1999; 18: 1660–1672.
Rhen T, Cidlowski JA . Antiinflammatory action of glucocorticoids—new mechanisms for old drugs. N Engl J Med 2005; 353: 1711–1723.
Kadmiel M, Cidlowski JA . Glucocorticoid receptor signaling in health and disease. Trends Pharmacol Sci 2013; 34: 518–530.
D'Adamio F, Zollo O, Moraca R, Ayroldi E, Bruscoli S, Bartoli A et al. A new dexamethasone-induced gene of the leucine zipper family protects T lymphocytes from TCR/CD3-activated cell death. Immunity 1997; 7: 803–812.
Cannarile L, Zollo O, D'Adamio F, Ayroldi E, Marchetti C, Tabilio A et al. Cloning, chromosomal assignment and tissue distribution of human GILZ, a glucocorticoid hormone-induced gene. Cell Death Differ 2001; 8: 201–203.
Bruscoli S, Donato V, Velardi E, Di Sante M, Migliorati G, Donato R et al. Glucocorticoid-induced leucine zipper (GILZ) and long GILZ inhibit myogenic differentiation and mediate anti-myogenic effects of glucocorticoids. J Biol Chem 2010; 285: 10385–10396.
Ayroldi E, Riccardi C . Glucocorticoid-induced leucine zipper (GILZ): a new important mediator of glucocorticoid action. FASEB J 2009; 23: 3649–3658.
Beaulieu E, Morand EF . Role of GILZ in immune regulation, glucocorticoid actions and rheumatoid arthritis. Nat Rev Rheumatol 2011; 7: 340–348.
Ayroldi E, Migliorati G, Bruscoli S, Marchetti C, Zollo O, Cannarile L et al. Modulation of T-cell activation by the glucocorticoid-induced leucine zipper factor via inhibition of nuclear factor kappaB. Blood 2001; 98: 743–753.
Cannarile L, Fallarino F, Agostini M, Cuzzocrea S, Mazzon E, Vacca C et al. Increased GILZ expression in transgenic mice up-regulates Th-2 lymphokines. Blood 2006; 107: 1039–1047.
Cannarile L, Cuzzocrea S, Santucci L, Agostini M, Mazzon E, Esposito E et al. Glucocorticoid-induced leucine zipper is protective in Th1-mediated models of colitis. Gastroenterology 2009; 136: 530–541.
Pinheiro I, Dejager L, Petta I, Vandevyver S, Puimege L, Mahieu T et al. LPS resistance of SPRET/Ei mice is mediated by Gilz, encoded by the Tsc22d3 gene on the X chromosome. EMBO Mol Med 2013; 5: 456–470.
Ayroldi E, Zollo O, Bastianelli A, Marchetti C, Agostini M, Di Virgilio R et al. GILZ mediates the antiproliferative activity of glucocorticoids by negative regulation of Ras signaling. J Clin Investig 2007; 117: 1605–1615.
Bruscoli S, Velardi E, Di Sante M, Bereshchenko O, Venanzi A, Coppo M et al. Long glucocorticoid-induced leucine zipper (L-GILZ) protein interacts with ras protein pathway and contributes to spermatogenesis control. J Biol Chem 2012; 287: 1242–1251.
Sengupta S, Wasylyk B . Physiological and pathological consequences of the interactions of the p53 tumor suppressor with the glucocorticoid, androgen, and estrogen receptors. Ann NY Acad Sci 2004; 1024: 54–71.
Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML et al. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 1993; 362: 849–852.
Sasson R, Tajima K, Amsterdam A . Glucocorticoids protect against apoptosis induced by serum deprivation, cyclic adenosine 3',5'-monophosphate and p53 activation in immortalized human granulosa cells: involvement of Bcl-2. Endocrinology 2001; 142: 802–811.
Yu C, Yap N, Chen D, Cheng S . Modulation of hormone-dependent transcriptional activity of the glucocorticoid receptor by the tumor suppressor p53. Cancer Lett 1997; 116: 191–196.
Crochemore C, Michaelidis TM, Fischer D, Loeffler JP, Almeida OF . Enhancement of p53 activity and inhibition of neural cell proliferation by glucocorticoid receptor activation. FASEB J 2002; 16: 761–770.
Urban G, Golden T, Aragon IV, Cowsert L, Cooper SR, Dean NM et al. Identification of a functional link for the p53 tumor suppressor protein in dexamethasone-induced growth suppression. J Biol Chem 2003; 278: 9747–9753.
Murphy SH, Suzuki K, Downes M, Welch GL, De Jesus P, Miraglia LJ et al. Tumor suppressor protein (p)53, is a regulator of NF-kappaB repression by the glucocorticoid receptor. Proc Natl Acad Sci USA 2011; 108: 17117–17122.
Soderberg O, Gullberg M, Jarvius M, Ridderstrale K, Leuchowius KJ, Jarvius J et al. Direct observation of individual endogenous protein complexes In situ by proximity ligation. Nat Methods 2006; 3: 995–1000.
Sandy P, Gostissa M, Fogal V, Cecco LD, Szalay K, Rooney RJ et al. p53 is involved in the p120E4F-mediated growth arrest. Oncogene 2000; 19: 188–199.
Chen J, Marechal V, Levine AJ . Mapping of the p53 and mdm-2 interaction domains. Mol Cell Biol 1993; 13: 4107–4114.
Kudo N, Matsumori N, Taoka H, Fujiwara D, Schreiner EP, Wolff B et al. Leptomycin B inactivates CRM1/exportin 1 by covalent modification at a cysteine residue in the central conserved region. Proc Natl Acad Sci USA 1999; 96: 9112–9117.
Oren M . Decision making by p53: life, death and cancer. Cell Death Differ 2003; 10: 431–442.
Kubbutat MH, Jones SN, Vousden KH . Regulation of p53 stability by Mdm2. Nature 1997; 387: 299–303.
Geng QQ, Dong DF, Chen NZ, Wu YY, Li EX, Wang J et al. Induction of p53 expression and apoptosis by a recombinant dual-target MDM2/MDMX inhibitory protein in wildtype p53 breast cancer cells. Int J Oncol 2013; 43: 1935–1942.
Haupt Y, Maya R, Kazaz A, Oren M . Mdm2 promotes the rapid degradation of p53. Nature 1997; 387: 296–299.
Kruse JP, Gu W . SnapShot: p53 posttranslational modifications. Cell 2008; 133: 930–930 e931.
Lahav G, Rosenfeld N, Sigal A, Geva-Zatorsky N, Levine AJ, Elowitz MB et al. Dynamics of the p53-Mdm2 feedback loop in individual cells. Nat Genet 2004; 36: 147–150.
Lee JT, Gu W . The multiple levels of regulation by p53 ubiquitination. Cell Death Differ 2010; 17: 86–92.
Freedman DA, Levine AJ . Nuclear export is required for degradation of endogenous p53 by MDM2 and human papillomavirus E6. Mol Cell Biol 1998; 18: 7288–7293.
Li M, Brooks CL, Wu-Baer F, Chen D, Baer R, Gu W . Mono- versus polyubiquitination: differential control of p53 fate by Mdm2. Science 2003; 302: 1972–1975.
Lai Z, Yang T, Kim YB, Sielecki TM, Diamond MA, Strack P et al. Differentiation of Hdm2-mediated p53 ubiquitination and Hdm2 autoubiquitination activity by small molecular weight inhibitors. Proc Natl Acad Sci USA 2002; 99: 14734–14739.
Zhang Y, Xiong Y, Yarbrough WG . ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell 1998; 92: 725–734.
Brooks CL, Li M, Hu M, Shi Y, Gu W . The p53—Mdm2—HAUSP complex is involved in p53 stabilization by HAUSP. Oncogene 2007; 26: 7262–7266.
Li L, Tao Q, Jin H, van Hasselt A, Poon FF, Wang X et al. The tumor suppressor UCHL1 forms a complex with p53/MDM2/ARF to promote p53 signaling and is frequently silenced in nasopharyngeal carcinoma. Clin Cancer Res 2010; 16: 2949–2958.
Yoon CH, Rho SB, Kim ST, Kho S, Park J, Jang IS et al. Crucial role of TSC-22 in preventing the proteasomal degradation of p53 in cervical cancer. PloS One 2012; 7: e42006.
Colaluca IN, Tosoni D, Nuciforo P, Senic-Matuglia F, Galimberti V, Viale G et al. NUMB controls p53 tumour suppressor activity. Nature 2008; 451: 76–80.
Yuan J, Luo K, Zhang L, Cheville JC, Lou Z . USP10 regulates p53 localization and stability by deubiquitinating p53. Cell 2010; 140: 384–396.
Kussie PH, Gorina S, Marechal V, Elenbaas B, Moreau J, Levine AJ et al. Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science 1996; 274: 948–953.
Wang S, El-Deiry WS . p73 or p53 directly regulates human p53 transcription to maintain cell cycle checkpoints. Cancer Res 2006; 66: 6982–6989.
Deffie A, Wu H, Reinke V, Lozano G . The tumor suppressor p53 regulates its own transcription. Mol Cell Biol 1993; 13: 3415–3423.
Khosravi R, Maya R, Gottlieb T, Oren M, Shiloh Y, Shkedy D . Rapid ATM-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage. Proc Natl Acad Sci USA 1999; 96: 14973–14977.
Bunz F, Hwang PM, Torrance C, Waldman T, Zhang Y, Dillehay L et al. Disruption of p53 in human cancer cells alters the responses to therapeutic agents. J Clin Investig 1999; 104: 263–269.
Zhang Q, Zeng SX, Zhang Y, Zhang Y, Ding D, Ye Q et al. A small molecule Inauhzin inhibits SIRT1 activity and suppresses tumour growth through activation of p53. EMBO Mol Med 2012; 4: 298–312.
Ayroldi E, Zollo O, Macchiarulo A, Di Marco B, Marchetti C, Riccardi C . Glucocorticoid-induced leucine zipper inhibits the Raf-extracellular signal-regulated kinase pathway by binding to Raf-1. Mol Cell Biol 2002; 22: 7929–7941.
Acknowledgements
This study was supported by a grant from the Associazione Italiana per la Ricerca sul Cancro (AIRC), Milan, Italy (IG 10677) to CR.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Edited by M Oren
Rights and permissions
About this article
Cite this article
Ayroldi, E., Petrillo, M., Bastianelli, A. et al. L-GILZ binds p53 and MDM2 and suppresses tumor growth through p53 activation in human cancer cells. Cell Death Differ 22, 118–130 (2015). https://doi.org/10.1038/cdd.2014.129
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/cdd.2014.129
This article is cited by
-
Long glucocorticoid-induced leucine zipper regulates human thyroid cancer cell proliferation
Cell Death & Disease (2018)
-
A dual role for glucocorticoid-induced leucine zipper in glucocorticoid function: tumor growth promotion or suppression?
Cell Death & Disease (2018)
-
Yeast two-hybrid screening identified WDR77 as a novel interacting partner of TSC22D2
Tumor Biology (2016)
